WallStreetZenWallStreetZen

NASDAQ: MTEM
Molecular Templates Inc Stock

$1.43+0.32 (+28.83%)
Updated Jun 12, 2024
MTEM Price
$1.43
Fair Value Price
N/A
Market Cap
$9.41M
52 Week Low
$1.02
52 Week High
$9.45
P/E
-1.29x
P/B
1.6x
P/S
0.38x
PEG
N/A
Dividend Yield
N/A
Revenue
$31.76M
Earnings
-$18.40M
Gross Margin
100%
Operating Margin
-53.89%
Profit Margin
-57.9%
Debt to Equity
3.62
Operating Cash Flow
-$28M
Beta
1.14
Next Earnings
Aug 8, 2024
Ex-Dividend
N/A
Next Dividend
N/A

MTEM Overview

Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases. The company primarily develops a pipeline of therapies through its proprietary biologic engineered toxin body (ETB) drug platform. The company is developing MT-5111, an ETB candidate that is in Phase I clinical trial for the treatment of HER2-positive cancers; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory myeloma patients; and MT-6402 in that is in Phase I clinical trial for PD-1/PD-L1 antibody relapsed/refractory patients. Its pipeline of ETBs in development for other targets, including CTLA-4, TIGIT, TROP2, BCMA, SLAMF-7, and CD45. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MTEM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

MTEM is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MTEM is good value based on its book value relative to its share price (1.6x), compared to the US Biotechnology industry average (6.31x)
P/B vs Industry Valuation
MTEM is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more MTEM due diligence checks available for Premium users.

Be the first to know about important MTEM news, forecast changes, insider trades & much more!

MTEM News

Valuation

MTEM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.29x
Industry
-9.14x
Market
30.03x

MTEM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.6x
Industry
6.31x
MTEM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

MTEM's financial health

Profit margin

Revenue
$11.1M
Net Income
$572.0k
Profit Margin
5.2%
MTEM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MTEM's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$27.1M
Liabilities
$21.2M
Debt to equity
3.62
MTEM's short-term assets ($10.69M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MTEM's long-term liabilities ($12.67M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MTEM's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MTEM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.2M
Investing
$0.0
Financing
$0.0
MTEM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

MTEM vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
MTEM$9.41M+28.83%-1.29x1.60x
ABVC$9.31M+0.94%-0.38x1.19x
BRTX$9.14M+15.38%-0.99x0.63x
ALLR$8.98M+4.08%-0.00x-1.39x
MBRX$9.99M+0.70%-0.33x0.46x

Molecular Templates Stock FAQ

What is Molecular Templates's quote symbol?

(NASDAQ: MTEM) Molecular Templates trades on the NASDAQ under the ticker symbol MTEM. Molecular Templates stock quotes can also be displayed as NASDAQ: MTEM.

If you're new to stock investing, here's how to buy Molecular Templates stock.

What is the 52 week high and low for Molecular Templates (NASDAQ: MTEM)?

(NASDAQ: MTEM) Molecular Templates's 52-week high was $9.45, and its 52-week low was $1.02. It is currently -84.87% from its 52-week high and 40.2% from its 52-week low.

How much is Molecular Templates stock worth today?

(NASDAQ: MTEM) Molecular Templates currently has 6,583,880 outstanding shares. With Molecular Templates stock trading at $1.43 per share, the total value of Molecular Templates stock (market capitalization) is $9.41M.

Molecular Templates stock was originally listed at a price of $7,068.60 in Feb 4, 2005. If you had invested in Molecular Templates stock at $7,068.60, your return over the last 19 years would have been -99.98%, for an annualized return of -36.09% (not including any dividends or dividend reinvestments).

How much is Molecular Templates's stock price per share?

(NASDAQ: MTEM) Molecular Templates stock price per share is $1.43 today (as of Jun 12, 2024).

What is Molecular Templates's Market Cap?

(NASDAQ: MTEM) Molecular Templates's market cap is $9.41M, as of Jun 13, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Molecular Templates's market cap is calculated by multiplying MTEM's current stock price of $1.43 by MTEM's total outstanding shares of 6,583,880.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.